Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 瘤学和致癌症
  5. 预测和预后标志物
  6. 在三阴性乳腺癌中,rbm15通过向tnfsf9的甲基化和诱导瘤相关巨细胞向m2表型的两极化来增强帕克利塔塞尔耐药性.

在三阴性乳腺癌中,RBM15通过向TNFSF9的甲基化和诱导瘤相关巨细胞向M2表型的两极化来增强帕克利塔塞尔耐药性.

Jinkun Fu1, Chao Wei1, Yijian Chen1

  • 1Department of General Surgery, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China.

Hereditas
|August 20, 2025

相关实验视频

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.7K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K

在PubMed 上查看摘要

概括
此摘要是机器生成的。

通过增强TNFSF9的m6A甲基化,导致M2巨分化,促进三阴性乳腺癌 (TNBC) 中的帕克利塔塞尔耐药性. 这一发现为克服TNBC药物耐药性的潜在治疗目标提供了帮助.

科学领域:

  • 癌症学
  • 分子生物学
  • 免疫学

背景情况:

  • 三重阴性乳腺癌 (TNBC) 预后不佳,治疗选择有限.
  • 对化疗的耐药性是TNBC治疗的一个主要挑战.
  • 了解化学抵抗的机制对于开发有效疗法至关重要.

研究的目的:

  • 研究RNA结合动机蛋白15 (RBM15) 在TNBC中对帕克利塔塞尔 (PTX) 耐药性的作用.
  • 阐明RBM15赋予PTX抗性的分子机制.
  • 探索RBM15对瘤微环境的影响,特别是巨细胞两极分化.

主要方法:

  • 生物信息学分析以识别PTX抗性TNBC细胞中的上调基因.
  • 抗PTX的TNBC细胞系的构造和表征 (MDA-MB-231/PTX,MDA-MB-468/PTX).
  • 使用各种测定方法 (CCK-8,EDU,流细胞计,Transwell) 评估细胞活力,增殖,亡,迁移,入侵和巨分化.
  • 检测TNFSF9和RBM15蛋白质和mRNA水平 (西斑,RT-qPCR).
  • 通过m6A修饰试验 (RIP,MeRIP) 分析RBM15-TNFSF9的相互作用.
  • 使用异种移植瘤模型进行体内验证.

主要成果:

关键词:
M2极化情况对PTX的抗性一个RBM15其他类型

相关实验视频

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.7K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K
  • 在抗PTX的TNBC细胞中TNFSF9的表达很高,其沉默增加了PTX的敏感性.
  • 抑制TNFSF9将巨细胞偏向从M2转移到M1,改变细胞因子 (减少IL-10,TGF-β;增加IL-1β,TNF-α).
  • 发现RBM15通过m6A修饰来调节TNFSF9的表达.
  • 在体外和体内,TNFSF9的过度表达逆转了RBM15沉默的瘤抑制作用.
  • 患者样本证实了RBM15在PTX抗性TNBC组织中高TNFSF9表达中的作用.

结论:

  • 通过增强TNFSF9的m6A甲基化,RBM15促进了TNBC中的PTX耐药性.
  • 这一过程导致与瘤相关的巨细胞的M2两极分化,导致化学抵抗.
  • 针对RBM15/TNFSF9轴可能是克服TNBC中PTX耐药性的新疗法.
三重阴性乳腺癌